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Evaluation of the MB/BacT System for recovery of mycobacteria from
clinical specimens in comparison to Lowenstein–Jensen medium
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Objective To evaluate the performance of the MB/BacT system (Organon Teknika) in
comparison to Lowenstein–Jensen (LJ) solid medium for recovery of mycobacteria from
clinical specimens.
Methods Two thousand three hundred and ten specimens (1626 respiratory, 593 urine,
60 body fluids, five tissue and 26 others) were inoculated in MB/BacT (0.5 mL) and on
two LJ slants (0.25 mL each). N-acetyl-L-cysteine-NaOH (final concentration 2%) was
used for decontamination.
Results Two hundred and fifty-one (10.8%) mycobacterial isolates [190 Mycobacterium
tuberculosis complex (MTBC) and 61 non-tuberculous mycobacteria (NTM)] were
detected. Of these 251 isolates, 234 (93.2%; 181 MTBC and 53 NTM) were detected in
MB/BacT and 169 (67.3%; 154 MTBC and 15 NTM) on LJ. The mean (median) times to
detection of MTBC by MB/BacT and LJ were 13.8 (13) and 22.1 (20) days, respectively,
while overall contamination rates were 7.7% and 8.1%, respectively.
Conclusions Sensitivity and time to detection were significantly better with MB/BacT
than with solid LJ medium.
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I N T R O D U C T I O N
Tuberculosis is on the increase throughout the
world and remains one of the few infectious dis-
eases diagnosis which often relies on clinical sus-
picion. The majority of routine clinical laboratories
still depend on the acid-fast bacilli (AFB) smear
and culture on solid media, usually Lowenstein–
Jensen (LJ) diagnosis. Microscopy, although quick
and easy, has poor sensitivity. Culture on solid
media is more specific and sensitive, but can take
several weeks. Liquid culture using a radiometric
method (BACTEC 460 TB) is faster but cannot be
implemented in every laboratory, for safety rea-
sons. So far, the Standard has been the combina-
tion of the BACTEC 460 TB system and solid
culture media [1]. Sensitivity, specificity and the
low detection time of the radioactive method have
been demonstrated in early studies [2,3]. More
recently, new liquid media-based systems have
been introduced for expedited isolation of the
Mycobacterium tuberculosis complex (MTBC), for
indirect susceptibility testing, and for shortened
detection time in conjunction with nucleic acid
probes [1,4,5]. These systems include: Becton-
Dickinson’s MGIT (Becton Dickinson, Cockeys-
ville, MD, USA) and fluorescent 9000 MB system,
Difco’s ESP (Difco Laboratories, Detroit, MC,
USA), and Organon Teknika’s MB/BacT (Organon
Teknika, Durham, NC, USA). The recent develop-
ment of DNA amplification by the polymerase
chain reaction (PCR) permits rapid detection of
mycobacteria in clinical specimens. However, in
practice, limitations of the method include pro-
blems of contamination, inhibition, and differ-
ences in sensitivity and specificity related to the
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
Corresponding author and reprint requests: V. Mirovic,
Military Medical Academy, Department of Microbiology,
Crnotravska 17, 11000 Beograd, Yugoslavia
Tel: þ381 11 66 22 66
E-mail: mmirovic@yahoo.com
particular target sequence for DNA amplification
as well as the protocol employed [6,7].
Today, ‘the driving force for the clinical labora-
tory is to provide ever more rapid species identi-
fication and antimycobacterial drug susceptibility
profiles’, because of altered clinical and epidemio-
logical situations over recent years [1,8]. The emer-
gence of clinically significant non-tuberculous
mycobacteria (NTM), especially in immunocom-
promised hosts, poses an additional challenge for
patient care.
The aim of this study was to evaluate the perfor-
mance of the MB/BacT system (Organon Teknika)
in comparison with culture on LJ medium.
M A T E R I A L S A N D M E T H O D S
Specimens
Two thousand three hundred and ten specimens
from 1138 patients, collected by the Clinical Micro-
biology Department of the Military Medical Acad-
emy, Belgrade, Yugoslavia between October 1998
and November 1999, were included in the study.
Specimens processed for mycobacterial culture
included 1626 respiratory specimens (sputum,
bronchial washing and aspirate, pleural fluid,
and pharyngeal swab), 593 urine samples, 60 nor-
mally sterile body fluids (pericardial fluid, cere-
brospinal fluid, synovial fluid, and ascites), five
tissue samples, and 26 others (stools, pus).
Specimen processing
Respiratory specimens, except pleural fluid, and
contaminated site specimens were decontami-
nated by the addition of an equal volume of N-
acetyl-L-cysteine-NaOH (final concentration 2%).
After 15 min at room temperature this mixture was
neutralized with phosphate-buffered saline (PBS)
at pH 6.8 and concentrated by centrifugation at
3000 g for 15 min [1]. Specimens collected from
sterile sites were concentrated by centrifugation
and were cultured without prior decontamination.
Tissue specimens were ground in sterile 0.9%
NaCl before centrifugation. The sediment obtained
after centrifugation was resuspended in 2 mL of PBS
and was used for inoculation of the media.
Cultivation
Each MB/BacT bottle was inoculated with 0.5 mL
of sediment, while two LJ slants were each inocu-
lated with 0.25 mL of sediment. For the ligase chain
reaction (LCR) probe (performed only for smear-
positive specimens) 0.5 mL of sediment was used,
and a small amount (except from urine specimens)
was used to prepare for auramine staining [1].
MB/BacT bottles were loaded in the instrument
for continuous monitoring over 42 days, LJ slants
were incubated for 70 days at 37 8C (first 2 weeks in
5% CO2) and were read for growth twice a week
for the first 4 weeks and weekly thereafter. When
growth was observed on LJ medium or signalled
by MB/BacT instrument, an AFB smear was made
to determine whether the cultures contained
mycobacteria or contaminants. Samples of broth
from MB/BacT bottles with a positive signal were
subcultured on LJ slants. We were not looking for
mycobacteria requiring other than 37 8C incuba-
tion temperatures, special growth factors, or pro-
longed incubation time.
Identification of mycobacteria
Mycobacterial isolates were identified using con-
ventional methods [1]. For the LCR, theLCx Myco-
bacterium tuberculosis Assay was performed in
accordance with the instructions of manufacturer
(Abbott Diagnostics, Abbot Park, IL, USA). The
amplification product was detected automatically
by Microparticle Enzyme Immunoassay.
Statistical analysis
The statistical significance of differences in recov-
ery rates was determined by the w2 test (number of
culture-positive specimens) and proportion t-test
(number of patients with tuberculosis). The statis-
tical differences in isolation times (only the paired
values used) were determined by the Wilcoxon
signed-rank test. Clinical assessment included by
review a tuberculosis expert as well as considera-
tion of the results obtained from additional speci-
mens.
R E S U L T S
Specimens and patients
Mycobacteria were isolated from 251 (10.9%) of the
total of 2310 clinical specimens. From 593 speci-
mens of urine (smear examinations were not per-
formed), we obtained 18 isolates of mycobacteria
(15 MTBC and three NTM); and from the total of
the other 1717 specimens, for which smear exam-
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inations were performed, 233 (13.6%) isolates of
mycobacteria were recovered (175 MTBC and 58
NTM): 125 (53.6%) from acid-fast smear-positive
and 108 (46.4%) from acid-fast smear-negative
specimens.
NTM were detected in 61 specimens from 52
patients. None of the specimens that were culture-
positive for NTM were smear-positive. NTM were
recovered from sputa (55 isolates from 46
patients), bronchial washings (three isolates from
three patients), and urines (three isolates from
three patients). None of these patients had clinical
evidence of mycobacterial disease. Since all iso-
lates of NTM were considered as contaminants,
and the patients were not treated with antimyco-
bacterial agents, these isolates were neither further
identified nor included in detailed evaluations.
Most of the isolates of MTBC (173) were recov-
ered from respiratory specimens, 15 from urines,
one from pericardial fluid, and one from lymph
node. In total 69 patients were detected, from
whom MTBC were recovered for the first time,
and three patients in whom it was recovered
following response to treatment. In five patients
MTBC were recovered in urines by both the MB/
BacT and LJ culture systems (smear examinations
were not performed). From the other specimens
MTBC were isolated from 67 patients: 65 patients
from respiratory specimens (included two from
pleural fluids and three following a response to
treatment), one from pericardial fluid, and one
from lymph node biopsy.
Recovery rates by MB/BacT system and LJ
The overall recovery rate of mycobacteria by the
MB/BacT system was higher than that with LJ
(Table 1). The smear and culture results for 175
MTBC culture-positive specimens are shown in
Table 2. MTBC grew from 125 (80.6%) of 155
smear-positive specimens. The 30 smear-positive
culture-negative specimens (Table 3) included 21
specimens from three patients with previously
positive cultures of MTBC during treatment, eight
specimens from patients with previously positive
Table 1 Rates of recovery of MTBC
and NTM isolates by MB/BacT and
LJ culture systems from 2310 speci-
mens
Number (%) of isolates by
Species
(no. of isolates)
MB/BacT
system
LJ
system P-value
MTBC (190) 181 (95.3) 154 (81.1) <0.001
NTM (61) 53 (86.9) 15 (24.6) <0.001
Total (251) 234 (93.2) 169 (67.3) <0.001
MTBC, Mycobacterium tuberculosis complex; NTM, non-tuberculous mycobacteria;
LJ, Lowenstein–Jensen.
Table 2 Smear and culture results
for 175 MTBC-positive cultures Number of positive cultures
(% recovery)
Smear resulta No. of smears MB/BacT LJ P-value
Positive 125 120 (96) 99 (79.2) <0.001
Negative 50 46 (92) 42 (84) NS
Total 175 166 (94.9) 141 (80.6) <0.001
MTBC, Mycobacterium tuberculosis complex; LJ, Lowenstein–Jensen; NS, not
significant.
aSmear examinations were performed for 1717 specimens.
Table 3 Culture results of smear-positive, culture-negative
specimensa
Culture in MB/BacT and on LJ slants
No. of
specimens
Both contamination 10
LJ contamination; MB/BacT-negative 5
MB/BacT contamination; LJ-negative 3
Both negative 12
Total 30
LJ, Lowenstein–Jensen.
aSmear examinations were performed for 1717 specimens.
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cultures of MTBC in less than 7 days, and one
pharyngeal swab from a patient with documented
pulmonary tuberculosis and a positive MTBC LCR
probe.
Of the 175 culture-positive specimens that grew
MTBC, the MB/BacT and LJ results were culture
negative on nine and 34 occasions, respectively.
Six of the nine isolates missed by the MB/BacT
system were lost bacause of contamination; of the
34 isolates missed by LJ, 24 were lost because of
contamination. Thus, the MB/BacT system and LJ
slants offered an advantage for the growth per se in
10 and three cases, respectively.
There were three patients in whom we detected
MTBC by positive smear results (cultures in MB/
BacT and on LJ were contaminated or negative),
confirmed by LCR probes: one patient with pul-
monary tuberculosis from whom we received only
one specimen as a pharyngeal swab and two
patients with pulmonary tuberculosis following
a response to treatment (Table 4). The MB/BacT
system revealed six patients in whom LJ cultures
were negative or contaminated: four patients with
pulmonary tuberculosis, one patient with tuber-
culous pleurisy, and one patient with pulmonary
tuberculosis during follow-up of treatment. LJ
cultures revealed three patients in whom MB/
BacT cultures were negative or contaminated:
two patients with pulmonary tuberculosis and
one patient with lymph node tuberculosis. There
was no statistical significance in differences of
recovery rates between MB/BacT and LJ culture
system.
Contamination rate
The contamination rate for all specimens inocu-
lated in the MB/BacT system was 7.7% (177 speci-
mens of 2310). A total of 8.1% (186 of 2310) of both
LJ slants were contaminated. The contamination
rate of specimens in which MTBC were detected
(205) was higher for LJ (19%) than for the MB/
BacT system (9.3%).
Mean (median) time to detection
The overall mean (median) times to detection of
MTBC were 14.2 (13) days for the MB/BacT system
and 22.4 (20) days for LJ (P< 0.001). The mean
(median) time to detection of NTM by MB/BacT
was 19.3 (23) days. Times to detection of NTM by
LJ were not recorded. The mean and median times
required for the recovery of MTBC according to
the smear results by both culture systems is pre-
sented in Table 5.
The mean (median) times for detection of the
patients with tuberculosis, taking into account the
first three specimens, for the MB/BacT and LJ
culture system were 13.7 (12) and 21.7 (18) days,
respectively (P< 0.001). For the patients for whom
all specimens were smear-negative the mean
(median) times to detection by MB/BacT and LJ
were 20.6 (17.5) and 33.3 (27) days, respectively
(P< 0.01).
Table 4 Rates for patients in whom we detected MTBC by
different methods from 1717 specimensa
Method
No. (%)
of patients
AFB smear-positive, culture-negative; 3 (4.5)b
confirmed by LCR probes
MB/BacT only 6 (9.0)c
LJ only 3 (4.5)
MB/BacT total 61 (91.0)d
LJ total 58 (86.6)d
Total 67 (100.0)
MTBC, Mycobacterium tuberculosis complex; AFB, acid-fast
bacilli; LCR, ligase chain reaction; LJ, Lowenstein–Jensen
aThe staining was not done for urine specimens; from 593
urine specimens we isolated MTBC in five patients by both
MB/BacT and LJ media, simultaneously.
bIncluded two patients following a response to treatment.
cIncluded one patient following a response to treatment.
dNot significant.
Mean (range) and median time
Smear resulta MB/BacT system LJ slants P-value
Positive 11.3 (4–36) 10 18.1 (10–41) 18 <0.001
Negative 19.6 (5–40) 18 31.2 (15–71) 28 <0.001
Total 13.8 (4–40) 13 22.1 (10–71) 20 <0.001
MTBC, Mycobacterium tuberculosis complex; LJ, Lowenstein–Jensen.
aStaining was not performed for 593 urines specimens.
Table 5 Paired mean (range) and
median time (in days) to detection
of MTBC by MB/BacT system and
LJ media according to the smear
results
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D I S C U S S I O N
For the detection of mycobacteria, liquid-based
media such as BACTEC 460 and the Mycobacteria
Growth Indicator Tube (MGIT) have generally
been found to be more sensitive and to require
fewer days to become positive than do conven-
tional solid media [4,5]. The MB/BacT, like BAC-
TEC 460 and MGIT, processes growth by detection
of metabolic changes that occur in the medium. In
the literature, there are few clinical studies of the
MB/BacT system. The study design used in this
investigation was somewhat biased in favor of the
LJ culture system in that LJ slopes were incubated
for 10 weeks while MB/BacT bottles were incu-
bated for 6 weeks. Under the conditions of this
study, the MB/BacT system compared favourably
with LJ slants in terms of sensitivity (93.2% vs.
67.3%; P< 0.001). Published rates of Mycobacterium
spp. recovery range from 73.0% to 96.5% for the
MB/BacT system [9–13] and 53.6% to 95.9% for the
LJ culture system [10–13].
One of the disadvantages often mentioned about
culture in liquid medium is that it does not provide
visible colonies. This could increase the time re-
quired for identification and susceptibility testing
of the isolate. However, the direct testing of posi-
tive MB/BacT broth by AccuProbe, without prior
centrifugation, allows for the accurate and rapid
identification of MTBC [9]. Additionally, the pre-
sence of cords in MB/BacT broth is a reliable cri-
terion for rapid, predictive identification of MTBC
for laboratories with a high proportion of MTBC
when the smears are examined by a microbiologist
who has experience with AFB staining [9].
The recovery rate for NTM isolates on LJ was
lower than that by the MB/BacT system, 24.6%
and 86.9%, respectively. It is well-known that LJ is
not the best medium for the isolation of NTM
isolates, because LJ is designed primarily for the
growth of MTBC [13]. No patient from whom
NTM were isolated showed clinical evidence of
mycobacterial disease. Thus, one could argue that
detecting these isolates increases the apparent
contamination rate of MB/BacT bottles by an
additional 2.6%. However, approximately 2–10%
of all mycobacterial infections in the USA are due
to NTM, and a higher incidence may be observed
in patients with malignancy and acquired immu-
nodeficiency syndrome [8].
The rates of recovery of MTBC in this study
using the MB/BacT system and the LJ culture
system were 95.3% and 81.1%, respectively (P<
0.001). Published rates of MTBC recovery range
from 80.2% to 98.7% [11,13] for the MB/BacT sys-
tem and 67.6% to 95.9% for the LJ system [10,13].
From the infection control standpoint, the speed
of MTBC detection is most critical. In this study,
the overall mean times (urines included) to detect
MTBC were 14.2 and 22.4 days for MB/BacT and
LJ slants, respectively (P< 0.001). Others [12,14,15]
have shown that the MB/BacT system requires
much less time to detect MTBC than do LJ slants
(13.7–14.2 vs. 26.1–29.4 days).
In this study, the mean times to detection of
MTBC from smear-positive specimens for the MB/
BacT and LJ were 11.3 and 18.1 days, respectively
(P< 0.001). Published mean times to detection of
MTBC for smear-positive specimens for the MB/
BacT and LJ cultures were 11.5 vs. 16.7 days [16].
For the smear-negative specimens the mean times
to detection of MTBC for the MB/BacT and LJ
were 19.6 and 31.2 days, respectively (P< 0.001).
Published mean times to detection of MTBC for
smear-negative specimens range from 19.3 to
21 days for the MB/BacT system [13,16]and 26.3
for LJ slants [17].
Published contamination rates range from 1.8%
to 8.4% for the MB/BacT system [17,18] and 1.5%
to 13.3% for the LJ system [12,17]. In our study,
overall contamination rates were 7.7% and 8.1%
for MB/BacT and LJ, respectively. Surprisingly,
the culture failures of LJ medium were primarily
from smear-positive specimens. The contamina-
tion rates in smear-positive specimens for the MB/
BacT system and LJ medium were 11% and 23.9%,
respectively, while in smear-negative specimens
the contamination rates were much lower for both
of them (4% each).
In this study there were 30 smear-positive, cul-
ture-negative specimens, mainly from three
patients (21 specimens) during treatment. All 12
smear-positive, culture-negative (MB/BacT and
LJ) specimens (Table 3) derived from patients dur-
ing treatment. Unfortunately, the incubation times
of MB/BacT bottles for these specimens were not
prolonged.
In conclusion, the sensitivity and time to detec-
tion of MTBC for the MB/BacT system were com-
parable to those obtained in published works [10–
13,15,16] while the contamination rate was slightly
higher [10–13,15,18]. Neither the MB/BacT nor the
LJ culture system detected all of the MTBC-posi-
tive specimens and patients with tuberculosis. The
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 8, 709–714
Mirovic and Lepsanovic Evaluation of MB/BacT System for mycobacteria recovery 713
present work indicates that the MB/BacT system
has great potential: it is a rapid, sensitive, efficient,
safe, simple-to-use, and fully automated method
for the isolation of mycobacteria.
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